New method for detecting MicroRNA in breast cancer patients
Official title: A New Detection Method for MicroRNA in Patients With Breast Cancer
Run by Tongji Hospital · NCT06529614 · Data updated 2026-11-12
This study is testing a new way to detect MicroRNA in the blood of breast cancer patients to see if it can help track the disease and how well treatments are working.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | Women only |
| Enrollment | 100 (estimated) |
| Sponsor | Tongji Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | July 20, 2024 |
| Main results expected | September 1, 2025 |
| Study ends | November 1, 2025 |
| Registry record updated | October 6, 2025 |
| Trial ID | NCT06529614 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients diagnosed with breast cancer who are healthy otherwise and do not have serious comorbidities.
✕Probably not a fit
Patients with serious diseases or conditions that may interfere with the results of the MicroRNA detection will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on developing a novel in-situ detection method for MicroRNA in the serum of patients diagnosed with breast cancer. The approach aims to improve the accuracy of MicroRNA detection, which could enhance the understanding of breast cancer progression and treatment response. By analyzing serum samples, the study seeks to establish a reliable biomarker for monitoring the disease. The methodology involves collecting serum samples from participants and applying the new detection technique to assess MicroRNA levels.
Why it matters
Potential benefit: If successful, this method could provide a more accurate and non-invasive way to monitor breast cancer progression and treatment efficacy.
How similar studies have gone: While there have been studies exploring MicroRNA detection in cancer, this specific in-situ detection method is novel and has not been widely tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Healthy without serious diseases \- Exclusion Criteria: * situations that may affect the results
Where it's running
-
Tongji Hospital
Wuhan, Hubei, China Recruiting
Study contacts
- Study coordinator: Lei Dou, Dr.
- Email: 616732045@qq.com
- Phone: 15171473498
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.